Skip to main content

Table 3 Patients’ characteristics

From: Long-term cost-utility analysis of remote monitoring of older patients with pacemakers: the PONIENTE study

 

All

RM group (n = 21)

CM group (n = 34)

p-value

Age (mean) ± SD

81.00 ± 6.47

81.14 ± 7.30

80.91 ± 6.01

0.690

Women (%)

17 (30.91)

8 (38.10)

9 (26.47)

0.365

Attrition (a)

28 (34.14)

9 (27.58)

18 (33.96)

0.481

Pacing indication (%)(b)

 Sinus node disease

11 (20.00)

3 (14.29)

8 (23.53)

0.493

 Atrioventricular block

39 (70.91)

15 (71.43)

24 (70.59)

 Others

5 (9.09)

3 (14.29)

2 (5.88)

Disease manifestations (%)(b)

 Syncope

33 (60.00)

13 (61.90)

20 (58.82)

0.681

 Dizziness

16 (29.09)

7 (33.33)

9 (26.47)

 Dyspnoea

3 (5.45)

0 (0)

3 (8.82)

 Angina

3 (5.45)

1 (4.76)

2 (5.88)

  1. CM Conventional monitoring; RM Remote monitoring
  2. (a) Concerned to the total initial patients (83)
  3. (b) Indications and manifestations before the PM implant over the remaining sample at the end of the study